Grace Therapeutics (GRCE) Return on Capital Employed [ROCE] (2020 - 2026)
Grace Therapeutics' Return on Capital Employed [ROCE] was -41.86% in fiscal Q1 2027 (quarter ended Jun 30, 2026), down 20.26 percentage points from -21.59% a year earlier and down 24.92 percentage points from the prior quarter.
Powered by 
Analysis
Grace Therapeutics (GRCE) Return on Capital Employed [ROCE] (2020 - 2026) Analysis & Trends
For FY2026 (ended Mar 31, 2026), Return on Capital Employed [ROCE] at Grace Therapeutics came in at -16.49%, up 7.10 percentage points from FY2025.
- Return on Capital Employed [ROCE] shows a five-year change of +23.48 percentage points (FY2021 to FY2026).
- In earlier fiscal years, Return on Capital Employed [ROCE] was -23.59% in FY2025 (-6.34 pp), -17.24% in FY2024 (+34.67 pp), -51.92% in FY2023 (-35.02 pp) and -16.89% in FY2022 (+23.08 pp).
- The fiscal Q1 2027 figure marks the lowest quarterly Return on Capital Employed [ROCE] since fiscal Q3 2024.
- Compared with a year earlier, Return on Capital Employed [ROCE] was higher in five of the last eight quarters, with an average year-over-year change of +8.94 percentage points.
- The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was fiscal Q2 2022 (a gain of 172.71 percentage points); the worst was fiscal Q1 2024 (a drop of 56.05 percentage points).
- Per Business Quant data, GRCE's Return on Capital Employed [ROCE] in the three fiscal quarters before Q1 2027 was -16.93% (Q4 2026), -16.98% (Q3 2026) and -18.68% (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 17.52% |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 16.76% |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 11.86% |
| 10 | Grace Therapeutics | 32.47 Mn | -33.80 Mn | - | -41.86% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -41.86% |
| Mar 31, 2026 | -16.93% |
| Dec 31, 2025 | -16.98% |
| Sep 30, 2025 | -18.68% |
| Jun 30, 2025 | -21.59% |
| Mar 31, 2025 | -25.79% |
| Dec 31, 2024 | -27.34% |
| Sep 30, 2024 | -24.82% |
| Jun 30, 2024 | -19.39% |
| Mar 31, 2024 | -17.59% |
| Dec 31, 2023 | -63.19% |
| Sep 30, 2023 | -65.83% |
| Jun 30, 2023 | -70.00% |
| Mar 31, 2023 | -55.16% |
| Dec 31, 2022 | -16.02% |
| Sep 30, 2022 | -15.71% |
| Jun 30, 2022 | -13.95% |
| Mar 31, 2022 | -13.19% |
| Dec 31, 2021 | -11.82% |
| Sep 30, 2021 | -12.82% |
API Access
Grace Therapeutics Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=GRCE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "GRCE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=GRCE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();